Iqra Shafeeq Mughal

Dr. Iqra Shafeeq Mughal


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2021 in IEEE Access
Verified
Journal Article
Open access
SBSheraz Ahmad Babar
Sheraz Ahmad Babar
DRDr. Iftikhar Ahmad Rana
Dr. Iftikhar Ahmad Rana
IMIqra Shafeeq Mughal
Iqra Shafeeq Mughal
SKSafdar Abbas Khan
Safdar Abbas Khan
Lack of insulin production by pancreas causes high blood glucose level (BGL) in the diabetic patients. For their treatment, manual insulin intake is possible only during the day timings but not feasible during the night when the patient is sleeping. Artificial pancreas (AP) is used for the automatic regulation of BGL by continuous injection of insulin. The nonlinear Bergman’s Minimal Model (BMM) considers fixed meal disturbance which may actually vary continuously during medication due to meal intake or by doing exercise. This variation has been taken into account by the Extended Bergman’s Minimal Model (EBMM). In this paper, two nonlinear: Terminal Synergetic and State Feedback Linearization based controllers have been proposed for AP to regulate BGL using EBMM. Asymptotic stability of the proposed controllers has been proved using Lyapunov theory. Comparison of the proposed controllers with each other and that with PID controller has been done using MATLAB/Simulink. White noise has been added as the disturbance to further analyze the output performance of the proposed controllers. The Terminal Synergetic controller which performs better than others, has also been implemented on the data of six Type 1 diabetic patients available in the literature.

13 March 2023 in International Journal of Dynamics and Control
Verified
Journal Article
Closed access
PDF file
IMIqra Shafeeq Mughal
Iqra Shafeeq Mughal
LPL. Patané
L. Patané
Maria XibiliaMaria Xibilia
Maria Xibilia
Riccardo CaponettoRiccardo Caponetto
Riccardo Caponetto

23 November 2025 in Electronics
Verified
Journal Article
Open access
PDF file
IMIqra Shafeeq Mughal
Iqra Shafeeq Mughal
SKStefan Koch
Stefan Koch
LPL. Patané
L. Patané
MSMartin Steinberger
Martin Steinberger
Riccardo CaponettoRiccardo Caponetto
Riccardo Caponetto
NKNebojša Koledin
Nebojša Koledin
Type 1 diabetes is an autoimmune disease that occurs when the immune system unintentionally attacks and damages β cells in the pancreas, reducing the organ’s ability to produce insulin. An artificial pancreas is a technology that uses a pump to inject the appropriate amount of insulin subcutaneously after analysing information collected by sensors, including continuous blood glucose monitoring. Over the past thirty years, several methods for controlling an artificial pancreas have been investigated in clinical and simulation environments. The improved Hovorka model, a comprehensive nonlinear model that explains the effects of insulin on transport, disposal and endogenous synthesis in both accessible and inaccessible compartments for blood glucose control by insulin administration, is used for this research. The presented model has the characteristics of a switching nonlinear system. The work proposes to analyse different nonlinear control strategies for blood glucose regulation and shows the effectiveness of the linear model predictive control strategy compared to other nonlinear controllers used in the literature.